A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Clinical trial NCT07432958 · RECRUITING
Trial details
- NCT number
- NCT07432958
- Sponsor
- Appello Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2027-09-03
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.